What We Have Learned about Addiction from Animal Models of Drug Self-Administration
Eliot L. Gardner Ph.D.,
Corresponding Author
Eliot L. Gardner Ph.D.
From the Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Md.
Address correspondence to Dr. Gardner, Intramural Research Program, National Institute on Drug Abuse, Building C; Room 272, 5500 Nathan Shock Dr., Baltimore, MD 21224. E-mail: [email protected].Search for more papers by this authorEliot L. Gardner Ph.D.,
Corresponding Author
Eliot L. Gardner Ph.D.
From the Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Md.
Address correspondence to Dr. Gardner, Intramural Research Program, National Institute on Drug Abuse, Building C; Room 272, 5500 Nathan Shock Dr., Baltimore, MD 21224. E-mail: [email protected].Search for more papers by this authorAbstract
Self-administration of addictive drugs in laboratory animals has been widely used for decades as a tool for studying behavioral, neurobiological, and genetic factors in addiction. From such studies has come an enormous amount of information on brain mechanisms involved in addiction, on vulnerability factors in the addictive process, and on possible pharmacotherapeutic treatments for addiction. Modifications of the laboratory animal self-administration paradigmö including progressive ratio break-point models and the “reinstatement” model of relapse to drug-seeking behaviorö are currently increasing our knowledge of incentive motivational factors in addiction and of the mechanisms underlying relapse to drug self-administration behavior.
REFERENCES
- 1 Spragg SDS. Morphine addiction in chimpanzees. Comparative Psychology Monographs. 1940; 15(7): 1–132.
- 2 Weeks JR. Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats. Science. 1962; 138: 143–144.
- 3 Schuster CR, Thompson T. Self administration of and behavioral dependence on drugs. Annu Rev Pharmacol. 1969; 9: 483–502.
- 4 Griffiths RR, Bigelow CE, Liebson I. Experimental drug self-administration: generality across species and type of drug. Natl Inst Drug Abuse Res Monogr Ser. 1978; 20: 24–43.
- 5 Brady JV, Lucas SE. Testing Drugs for Physical Dependence Potential and Abuse Liability. Washington, DC: U.S. Government Printing Office; 1984. National Institute on Drug Abuse Research Monograph Series, no. 52.
- 6 Spealman RD, Goldberg SR. Drug self-administration by laboratory animals: control by schedules of reinforcement. Annu Rev Pharmacol Toxicol. 1978; 18: 313–339.
- 7
Yokel RA.
Intravenous self-administration: response rates, the effects of pharmacological challenges, and drug preferences. In: MA Bozarth, ed.
Methods of Assessing the Reinforcing Properties of Abused Drugs. New York City, NY: Springer-Verlag;1987: 1–33.
10.1007/978-1-4612-4812-5_1 Google Scholar
- 8
Weeks JR.
Long-term intravenous infusion. In: RD Meyers, ed.
Methods in Psychobiology. Vol. 2. New York City, NY: Academic Press;1972: 155–168.
10.1016/B978-0-12-512302-0.50010-9 Google Scholar
- 9 Smith SG, Davis WM. A method for chronic intravenous drug administration in the rat. In: S Ehrenpreis, A Neidle, eds. Methods in Narcotics Research. New York City, NY: Marcel Dekker;1975: 3–32.
- 10 Deneau G, Yanagita T, Seevers MH. Self-administration of psychoactive substances by the monkey: a measure of psychological dependence. Psychopharmacologia. 1969; 16: 30–48.
- 11 Yanagita T, Deneau GA, Seevers MH. Evaluation of pharmacologic agents in the monkey by long-term intravenous self or programmed administration. Excerpta Medica International Congress Series. 1965; 87: 453–457.
- 12 Findley JD, Robinson WW, Peregrino L. Addiction to secobarbital and chlordiazepoxide in the rhesus monkey by means of a self-infusion preference procedure. Psychopharmacologia. 1972; 26: 93–114.
- 13 Goldberg SR. Comparable behavior maintained under fixed-ratio and second-order schedules of food presentation, cocaine injection or d-amphetamine injection in the squirrel monkey. J Pharmacol Exp Ther. 1973; 186: 18–30.
- 14 Stretch R, Gerber GJ. A method for chronic intravenous drug administration in squirrel monkeys. Can J Physiol Pharmacol. 1970; 48: 575–581.
- 15 Jones BE, Prada JA. Relapse to morphine use in dog. Psychopharmacologia. 1973; 30: 1–12.
- 16
Smith JM,
Renault PF,
Schuster CR.
A mild restraint and chronic venous catherization system for cats.
Pharmacol Biochem Behav. 1975; 3: 713–715.
10.1016/0091-3057(75)90199-9 Google Scholar
- 17 Balster RL, Kilbey MM, Ellinwood EH Jr. Methamphetamine self-administration in the cat. Psychopharmacologia. 1976; 46: 229–233.
- 18 Goldberg SR, Hoffmeister F, Schlichting UU, et al. A comparison of pentobarbital and cocaine self-administration in rhesus monkeys: effects of dose and fixed-ratio parameter. J Pharmacol Exp Ther. 1971; 179: 277–283.
- 19 Downs DA, Woods JH. Codeine-and cocaine-reinforced responding in rhesus monkeys: effects of dose on response rates under a fixed-ratio schedule. J Pharmacol Exp Ther. 1974; 191: 179–188.
- 20 Pickens R, Thompson T. Cocaine-reinforced behavior in rats: effects of reinforcement magnitude and fixed ratio size. J Pharmacol Exp Ther. 1968; 161: 122–129.
- 21 Goldberg SR, Kelleher RT. Behavior controlled by scheduled injections of cocaine in squirrel and rhesus monkeys. J Exp Anal Behav. 1976; 25: 93–104.
- 22 Schlichting UU, Goldberg SR, Wuttke W, et al. d-Amphetamine self-administration by rhesus monkeys with different self-administration histories. Excerpta Medica International Congress Series. 1971; 220: 62–69.
- 23
Pickens R,
Meisch R,
McGuire LE.
Methamphetamine reinforcement in rats.
Psychonomic Science. 1967; 8: 371–372.
10.3758/BF03332245 Google Scholar
- 24 Pickens R, Harris WC. Self-administration of d-amphetamine by rats. Psychopharmacologia. 1968; 12: 158–163.
- 25 Balster RL, Schuster CR. A comparison of d-amphetamine, l-amphetamine and metham-phetamine self-administration in rhesus monkeys. Pharmacol Biochem Behav. 1973; 1: 167–172.
- 26 Yokel RA, Pickens R. Self-administration of optical isomers of amphetamine and methyl-amphetamine by rats. J Pharmacol Exp Ther. 1973; 187: 27–33.
- 27
Risner ME.
Intravenous self-administration of d- and l-amphetamine by dog.
Eur J Pharmacol. 1975; 32: 344–348.
10.1016/0014-2999(75)90302-7 Google Scholar
- 28 Gtestam KG, Andersson BE. Self- administration of amphetamine analogues in rats. Pharmacol Biochem Behav. 1975; 3: 229–233.
- 29 Johanson CE, Schuster CR. A choice procedure for drug reinforcers: cocaine and methylphenidate in the rhesus monkey. J Pharmacol Exp Ther. 1975; 193: 676–688.
- 30 Griffiths RR, Winger G, Brady JV, et al. Comparison on behavior maintained by infusions of eight phenylethylamines in baboons. Psychopharmacology. 1976; 50: 251–258.
- 31 Weeks JR, Collins RJ. Factors affecting voluntary morphine intake in self-maintained addicted rats. Psychopharmacologia. 1964; 6: 267–279.
- 32 Hoffmeister F, Schlichting UU. Reinforcing properties of some opiates and opioids in rhesus monkeys with histories of cocaine and codeine self-administration. Psychopharmacologia. 1972; 23: 55–74.
- 33 Collins RJ, Weeks JR. Relative potency of codeine, methadone, and dihydromorphinone to morphine in self-maintained addict rats. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1965; 249: 509–514.
- 34 Talley WH, Rosenblum I. Self-administration of dextropropoxyphene by rhesus monkeys to the point of toxicity. Psychopharmacologia. 1972; 27: 179–182.
- 35 Smith SG, Werner TE, Davis WM. Effect of unit dose and route of administration on self-administration of morphine. Psycho-pharmacology. 1976; 50: 103–105.
- 36 Werner TE, Smith SG, Davis WM. A dose-response comparison between methadone and morphine self-administration. Psycho-pharmacology. 1976; 47: 209–211.
- 37 Schuster CR, Balster RL. Self-administration of agonists. In: HW Kosterlitz, HOJ Collier, JE Villarreal, eds. Agonist and Antagonist Actions of Narcotic Analgesic Drugs. Baltimore, Md.: University Park Press;1973: 243–254.
- 38
Moreton JE,
Roehrs T,
Khazan N.
Drug self-administration and sleep-wake activity in rats dependent on morphine, methadone, or l-alpha-acetylmethadol.
Psychopharmacology. 1976; 47: 237–241.
10.1007/BF00427607 Google Scholar
- 39 Winger GD, Woods JH. The reinforcing property of ethanol in the rhesus monkey. I. Initiation, maintenance and termination of intravenous ethanol-reinforced responding. Ann NY Acad Sci. 1973; 215: 162–175.
- 40 Woods JH, Ikomi F, Winger G. The reinforcing property of ethanol. In: MK Roach, WM McIsaac, PJ Creaven, eds. Biological Aspects of Alcohol. Austin, Tex.: University of Texas Press;1971: 371–388.
- 41 Winger G, Stitzer ML, Woods JH. Barbiturate-reinforced responding in rhesus monkeys: comparisons of drugs with different durations of action. J Pharmacol Exp Ther. 1975; 195: 505–514.
- 42 Yanagita T, Takahashi S. Dependence liability of several sedative-hypnotic agents evaluated in monkeys. J Pharmacol Exp Ther. 1973; 185: 307–316.
- 43
Davis JD,
Lulenski GC,
Miller NE.
Comparative studies of barbiturate self-administration.
Int J Addict. 1968; 3: 207–214.
10.3109/10826086809042895 Google Scholar
- 44 Kelleher RT. Characteristics of behavior controlled by scheduled injections of drugs. Pharmacol Rev. 1975; 27: 307–323.
- 45 Balster RL, Johanson CE, Harris RT. Phencyclidine self-administration in the rhesus monkey. Pharmacol Biochem Behav. 1973; 1: 167–172.
- 46 Moreton JE, Meisch RA, Stark L, et al. Ketamine self-administration by the rhesus monkey. J Pharmacol Exp Ther. 1977; 203: 303–309.
- 47 Martellotta MC, Cossu G, Fattore L, et al. Self-administration of the cannabinoid receptor agonist WIN 55,212–2 in drug-naive mice. Neuroscience. 1998; 85: 327–330.
- 48 Ledent C, Valverde O, Cossu G, et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science. 1999; 283: 401–404.
- 49
Pickens R,
Thompson T.
Characteristics of stimulant drug reinforcement. In: T Thompson,
R Pickens, eds.
Stimulus Properties of Drugs. New York City, NY: Appleton;1971: 177–192.
10.1007/978-1-4757-0788-5_11 Google Scholar
- 50 Pickens R, Thompson T. Simple schedules of drug self-administration in animals. In: JM Singh, L Miller, H Lal, eds. Drug Addiction. Vol. 1. Experimental Pharmacology. Mount Kisko, NY: Futura;1972: 107–120.
- 51
Goldberg SR,
Kelleher RT.
Reinforcement of behavior by cocaine injections. In: EH Ellinwood,
MM Kilbey, eds.
Cocaine and Other Stimulants. New York City, NY: Plenum Press;1977: 523–544.
10.1007/978-1-4684-3087-5_25 Google Scholar
- 52 Balster RL, Schuster CR. Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. J Exp Anal Behav. 1973; 20: 119–129.
- 53 Dougherty J, Pickens R. Fixed-interval schedules of intravenous cocaine presentation in rats. J Exp Anal Behav. 1973; 20: 111–118.
- 54 Woods JH, Schuster CR. Reinforcement properties of morphine, cocaine, and SPA as a function of unit dose. Int J Addict. 1968; 3: 231–237.
- 55 Schuster CR, Woods JH. The conditioned reinforcing effects of stimuli associated with morphine reinforcement. Int J Addict. 1968; 3: 223–230.
- 56 Carney JM, Llewellyn ME, Woods JH. Variable interval responding maintained by intravenous codeine and ethanol injections in the rhesus monkey. Pharmacol Biochem Behav. 1977; 5: 577–582.
- 57 Thompson T, Schuster CR. Morphine self-administration, food-reinforced and avoidance behaviors in rhesus monkeys. Psychopharmacologia. 1964; 5: 87–94.
- 58 Anderson WW, Thompson T. Ethanol self-administration in water-satiated rats. Pharmacol Biochem Behav. 1974; 2: 447–454.
- 59 Meisch RA, Thompson T. Ethanol as a reinforcer: an operant analysis of ethanol dependence. In: JM Singh, H Lal, eds. Drug Addiction. Vol. 3. Neurobiology and Influences on Behavior. Miami, Fla.: Symposia Specialists;1974: 117–133.
- 60 Goldstein A. Addiction: From Biology to Drug Policy. New York City, NY: WH Freeman;1995.
- 61 Gardner EL. Brain reward mechanisms. In: JH Lowinson, P Ruiz, RB Millman, et al, eds. Substance Abuse: A Comprehensive Textbook, 3rd ed. Baltimore, Md.: Williams & Wilkins;1997: 51–85.
- 62 Harrigan SE, Downs DA. Self-administration of heroin, acetylmethadol, morphine, and methadone in rhesus monkeys. Life Sci. 1978; 22: 619–624.
- 63 Johanson CE, Balster RL, Bonese K. Self-administration of psychomotor stimulant drugs: the effects of unlimited access. Pharmacol Biochem Behav. 1976; 4: 45–51.
- 64
Risner ME,
Jones BE.
Self-administration of CNS stimulants by dog.
Psychopharmacologia
1975; 43: 207–213.
10.1007/BF00429252 Google Scholar
- 65 Risner ME, Jones BE. Characteristics of unlimited access to self-administered stimulant infusions in dogs. Biol Psychiatry. 1976; 11: 625–634.
- 66 Kramer JC, Fischman VS, Littlefield DC. Amphetamine abuse: pattern and effects of high doses taken intravenously. JAMA. 1967; 201: 305–309.
- 67 Yanagita T, Takahashi S. Development of tolerance to and physical dependence on barbiturates in rhesus monkeys. J Pharmacol Exp Ther. 1970; 172: 163–169.
- 68 Yokel RA, Pickens R. Drug level of d- and l-amphetamine during intravenous self-administration. Psychopharmacologia. 1974; 34: 255–264.
- 69 Roberts DCS, Bennett SA. Heroin self-administration in rats under a progressive ratio schedule of reinforcement. Psycho-pharmacology. 1993; 111: 215–218.
- 70 Roberts DCS. Self-administration of GBR 12909 on a fixed ratio and progressive ratio schedule in rats. Psychopharmacology. 1993; 111: 202–206.
- 71 Bozarth MA, Wise RA. Toxicity associated with long-term intravenous heroin and cocaine self-administration in the rat. JAMA. 1985; 254: 81–83.
- 72 De Wit H, Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology. 1981; 75: 134–143.
- 73 De Wit H, Stewart J. Drug reinstatement of heroin-reinforced responding in the rat. Psychopharmacology. 1983; 79: 29–31.
- 74
Stewart J,
De Wit H.
Reinstatement of drug-taking behavior as a method of assessing incentive motivational properties of drugs. In: MA Bozarth, ed.
Methods of Assessing the Reinforcing Properties of Abused Drugs. New York City, NY: Springer-Verlag;1987: 211–227.
10.1007/978-1-4612-4812-5_12 Google Scholar
- 75 Erb S, Shaham Y, Stewart J. Stress reinstates cocaine-seeking behavior after prolonged extinction and drug-free periods. Psycho-pharmacology. 1996; 128: 408–412.
- 76 Shaham Y, Stewart J. Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal. Psycho-pharmacology. 1995; 119: 334–341.
- 77 Shaham Y, Rajabi H, Stewart J. Relapse to heroin-seeking in rats under opioid maintenance: the effects of stress, heroin-priming, and withdrawal. J Neurosci. 1996; 16: 1957–1963.
- 78 Meil WM, See RE. Conditioned cued recovery of responding following prolonged withdrawal from self-administered cocaine in rats: an animal model of relapse. Behav Pharmacol. 1996; 7: 754–763.
- 79 McFarland K, Ettenberg A. Reinstatement of drug-seeking behavior produced by heroin-predictive environmental stimuli. Psychopharmacology. 1997; 131: 86–92.
- 80 Katner SN, Magalong JG, Weiss F. Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat. Neuropsychopharmacology. 1999; 20: 471–479.
- 81
Weeks JR,
Collins RJ.
Screening for drug reinforcement using intravenous self-administration in the rat. In: MA Bozarth, ed.
Methods of Assessing the Reinforcing Properties of Abused Drugs. New York City, NY: Springer-Verlag;1987: 35–43.
10.1007/978-1-4612-4812-5_2 Google Scholar
- 82
Brady JV,
Griffiths RR,
Hienz RD, et al.
Assessing drugs for abuse liability and dependence potential in laboratory primates. In: MA Bozarth, ed.
Methods of Assessing the Reinforcing Properties of Abused Drugs. New York City, NY: Springer-Verlag;1987: 45–85.
10.1007/978-1-4612-4812-5_3 Google Scholar
- 83
Meisch RA,
Carroll ME.
Oral drug self-administration: drugs as reinforcers. In: MA Bozarth, ed.
Methods of Assessing the Reinforcing Properties of Abused Drugs. New York City, NY: Springer-Verlag;1987: 143–160.
10.1007/978-1-4612-4812-5_7 Google Scholar
- 84
Amit Z,
Smith BR,
Sutherland EA.
Oral self-administration of alcohol: a valid approach to the study of drug self-administration and human alcoholism. In: MA Bozarth, ed.
Methods of Assessing the Reinforcing Properties of Abused Drugs. New York City, NY: Springer-Verlag;1987: 161–171.
10.1007/978-1-4612-4812-5_8 Google Scholar
- 85 Yanagita T. Prediction of drug abuse liability from animal studies. In: MA Bozarth, ed. Methods of Assessing the Reinforcing Properties of Abused Drugs. New York City, NY: Springer-Verlag;1987: 189–198.
- 86 Kornetsky C. Brain-stimulation reward: a model for the neuronal bases for drug-induced euphoria. Natl Inst Drug Abuse Res Monogr Ser. 1985; 62: 30–50.
- 87 Wise RA. Action of drugs of abuse on brain reward systems. Pharmacol Biochem Behav. 1980; 13(suppl 1): 213–223.
- 88 Wise RA. Neural mechanisms of the reinforcing action of cocaine. Natl Inst Drug Abuse Res Monogr Ser. 1984; 50: 15–33.
- 89 Wise RA, Bozarth MA. Brain substrates for reinforcement and drug self-administration. Prog Neuropsychopharmacol. 1981; 5: 467–474.
- 90 Esposito RU, Kornetsky C. Opioids and rewarding brain stimulation. Neurosci Biobehav Rev. 1978; 2: 115–122.
- 91 Wise RA, Bozarth MA. Brain reward circuitry: four circuit elements “wired” in apparent series. Brain Res Bull. 1984; 12: 203–208.
- 92 Wise RA, Rompre P-P. Brain dopamine and reward. Annu Rev Psychol. 1989; 40: 191–225.
- 93 Reid LD. Tests involving pressing for intracranial stimulation as an early procedure for screening likelihood of addiction of opioids and other drugs. In: MA Bozarth, ed. Methods of Assessing the Reinforcing Properties of Abused Drugs. New York City, NY: Springer-Verlag;1987: 391–420.
- 94 Olds J, Travis RP. Effects of chlorpromazine, meprobamate, pentobarbital and morphine on self-stimulation. J Pharmacol Exp Ther. 1960; 128: 397–404.
- 95 Olds ME. Facilitatory action of diazepam and chlordiazepoxide on hypothalamic reward behavior. J Comp Physiol Psychol. 1966; 62: 136–140.
- 96
Olds ME.
Comparative effects of amphetamine, scopolamine, chlordiazepoxide and diphenylhydantoin on operant and extinction behaviour with brain stimulation and food reward.
Neuropharmacology. 1970; 9: 519–532.
10.1016/0028-3908(70)90002-X Google Scholar
- 97
Nazzaro JM,
Seeger TF,
Gardner EL.
Morphine differentially affects ventral tegmental and substantia nigra brain reward thresholds.
Pharmacol Biochem Behav. 1981; 14: 325–331.
10.1016/0091-3057(81)90398-1 Google Scholar
- 98 Nazzaro JM, Gardner EL, Bridger WH, et al. Pentobarbital induces a naloxone-reversible decrease in mesolimbic self-stimulation thresholds. Soc Neurosci Abstr. 1981; 7: 262.
- 99 Herberg LJ, Rose IC. The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward. Psychopharmacology. 1989; 99: 87–90.
- 100 Gardner EL, Paredes W, Smith D, et al. Facilitation of brain stimulation reward by Δ9-tetrahydrocannabinol. Psychopharmacology. 1988; 96: 142–144.
- 101 Chen J, Gardner EL. In vivo brain microdialysis study of phencyclidine on presynaptic dopamine efflux in rat caudate nucleus. Soc Neurosci Abstr. 1988; 14: 525.
- 102 Di Chiara G, Imperato A. Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: studies with transcerebral dialysis in freely moving rats. Ann NY Acad Sci. 1986; 473: 367–381.
- 103 Gysling K, Wang RY. Morphine-induced activation of A10 dopamine neurons in rats brains. Brain Res. 1983; 277: 119–127.
- 104 Hernandez L, Hoebel BG. Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci. 1988; 42: 1705–1712.
- 105 Hommer DW, Pert A. The action of opiates in the rat substantia nigra: an electrophysiological analysis. Peptides. 1983; 4: 603–608.
- 106 Imperato A, Di Chiara G. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther. 1986; 239: 219–228.
- 107 Imperato A, Mulas A, Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol. 1986; 132: 337–338.
- 108 Kalivas PW, Widerlov E, Stanley D, et al. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther. 1983; 227: 229–237.
- 109 Kalivas PW, Duffy P, Dilts R, et al. Enkephalin modulation of A10 dopamine neurons: a role in dopamine sensitization. Ann NY Acad Sci. 1988; 537: 405–414.
- 110 Westerink BHC, Tuntler J, Damsma G, et al. The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. Naunyn Schmiedebergs Arch Pharmacol. 1987; 336: 502–507.
- 111 Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev. 1987; 94: 469–492.
- 112 Hoffmeister F, Wuttke W. Psychotropic drugs as negative reinforcers. Pharmacol Rev. 1975; 27: 419–428.
- 113 Kandel DA, Schuster CR. An investigation of nalorphine and perphenazine as negative reinforcers in an escape paradigm. Pharmacol Biochem Behav. 1977; 6: 61–71.
- 114 Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In: AG Gilman, LS Goodman, TW Rall, et al, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 7th ed. New York City, NY: Macmillan;1985: 387–445.
- 115
Rech R.
Neurolepsis: anhedonia or blunting of emotional reactivity
Behav Brain Sci. 1982; 5: 72–73.
10.1017/S0140525X00010578 Google Scholar
- 116 Downs DA, Woods JH. Fixed-ratio escape and avoidance-escape from naloxone in morphine-dependent monkeys: effects of naloxone dose and morphine pretreatment. J Exp Anal Behav. 1975; 23: 415–427.
- 117 Ettenberg A, Pettit HO, Bloom FE, et al. Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology. 1982; 78: 204–209.
- 118 Goldberg SR, Hoffmeister F, Schlichting U, et al. Aversive properties of nalorphine and naloxone in morphine-dependent rhesus monkeys. J Pharmacol Exp Ther. 1971; 179: 268–276.
- 119 Baxter BL, Gluckman MI, Scerni RA. Apomorphine self-injection is not affected by alpha-methylparatyrosine treatment: support for dopaminergic reward. Pharmacol Biochem Behav. 1976; 4: 611–612.
- 120 Pickens R, Meisch RA, Dougherty JA Jr. Chemical interactions in methamphetamine reinforcement. Psychol Rep. 1968; 23: 1267–1270.
- 121 Wilson MC, Schuster CR. Aminergic influences on intravenous cocaine self-administration by rhesus monkeys. Pharmacol Biochem Behav. 1974; 2: 563–571.
- 122 Yokel RA, Wise RA. Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science. 1975; 187: 547–549.
- 123 Yokel RA, Wise RA. Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology. 1976; 48: 311–318.
- 124 Gill CA, Holz WC, Zirkle CL, et al. Pharmacological modification of cocaine and apomorphine self-administration in the squirrel monkey. In: P Denker, C Radouco-Thomas, A Villeneuve, eds. Proceedings of the Tenth Congress of the Collegium Internationale Neuro-Psychopharmacologicum. New York City, NY: Pergamon Press;1978: 1477–1484.
- 125 De Wit H, Wise RA. Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Canad J Psychol. 1977; 31: 195–203.
- 126 Herling S, Woods JH. Chlorpromazine effects on cocaine-reinforced responding in rhesus monkeys: reciprocal modification of rate-altering effects of the drugs. J Pharmacol Exp Ther. 1980; 214: 354–361.
- 127 Johanson CE, Kandel DA, Bonese K. The effects of perphenazine on self-administration behavior. Pharmacol Biochem Behav. 1976; 4: 427–433.
- 128 Risner ME, Jones BE. Role of noradrenergic and dopaminergic processes in amphetamine self-administration. Pharmacol Biochem Behav. 1976; 5: 477–482.
- 129 Risner ME, Jones BE. Characteristics of -phenethylamine self-administration by dog. Pharmacol Biochem Behav. 1977; 6: 689–696.
- 130 Risner ME, Jones BE. Intravenous self-administration of cocaine and norcocaine by dogs. Psychopharmacology. 1980; 71: 83–89.
- 131 Stretch R. Discrete-trial control of cocaine self-injection behaviour in squirrel monkeys: effects of morphine, naloxone, and chlor-promazine. Can J Physiol Pharmacol. 1977; 55: 778–790.
- 132 Wilson MC, Schuster CR. The effects of chlorpromazine on psychomotor stimulant self-administration in the rhesus monkey. Psychopharmacologia. 1972; 26: 115–126.
- 133 Wilson MC, Schuster CR. The effects of stimulants and depressants on cocaine self-administration behavior in the rhesus monkey. Psychopharmacologia. 1973; 31: 291–304.
- 134 Davis WM, Smith SG. Noradrenergic basis for reinforcement associated with morphine action in nondependent rats. In: JM Singh, H Lal, eds. Drug Addiction. Vol. 3. Neurobiology and Influ-ences on Behavior. Miami, Fla.: Symposia Specialists;1974: 155–168.
- 135 Hanson HM, Cimini-Venema CA. Effects of haloperidol on self-administration of morphine in rats. Fed Proc. 1972; 31: 503.
- 136 Roberts DCS, Vickers G. Atypical neuroleptics increase self-administration of cocaine: an evaluation of a behavioral screen for antipsychotic activity. Psychopharmacology. 1984; 82: 135–139.
- 137 De La Garza R, Johanson CE. Effects of haloperidol and physostigmine on self-administration of local anesthetics. Pharmacol Biochem Behav. 1982; 17: 1295–1299.
- 138 Woolverton WL. Effects of a D1 and D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacol Biochem Behav. 1986; 24: 531–535.
- 139 Jnsson LE, Gunne LM, Nggard E. Effects of alpha-methyltyrosine in amphetamine-dependent subjects. Pharmacol Clin. 1969; 2: 27–29.
- 140 Jnsson L, Nggard E, Gunne L. Blockade of intravenous amphetamine euphoria in man. Clin Pharmacol Ther. 1971; 12: 889–896.
- 141 Jinsson LE. Pharmacological blockade of amphetamine effects in amphetamine dependent subjects. Eur J Clin Pharmacol. 1972; 4: 206–211.
- 142 Gunne LM, Nggard E, Jinsson LE. Clinical trails with amphetamine-blocking drugs. Psychiat Neurol Neurochir. 1972; 75: 225–226.
- 143 Yokel RA, Wise RA. Amphetamine-type reinforcement by dopaminergic agonists in the rat. Psychopharmacology. 1978; 58: 289–296.
- 144
Roberts DCS,
Zito KA.
Interpretation of lesion effects on stimulant self-administration. In: MA Bozarth, ed.
Methods of Assessing the Reinforcing Properties of Abused Drugs. New York City, NY: Springer-Verlag;1987: 87–103.
10.1007/978-1-4612-4812-5_4 Google Scholar
- 145 Roberts DCS, Corcoran ME, Fibiger HC. On the role of ascending catecholamine systems in self-administration of cocaine. Pharmacol Biochem Behav. 1977; 6: 615–620.
- 146 Roberts DCS, Koob GF. Disruption of cocaine self-administration following 6–hydroxy-dopamine lesions of the ventral tegmental area in rats. Pharmacol Biochem Behav. 1982; 17: 901–904.
- 147 Moore RY, Bloom FE. Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. Annu Rev Neurosci. 1978; 1: 129–169.
- 148 Lyness WH, Friedle NM, Moore KE. Destruction of dopaminergic nerve terminals in nucleus accumbens: effect on d-amphetamine self-administration. Pharmacol Biochem Behav. 1979; 11: 553–556.
- 149 Glick SD, Cox RS, Crane AM. Changes in morphine self-administration and morphine dependence after lesions of the caudate nucleus in rats. Psychopharmacologia. 1975; 41: 219–224.
- 150 Bozarth MA, Wise RA. Heroin reward is dependent on a dopaminergic substrate. Life Sci. 1981; 29: 1881–1886.
- 151 Spyraki C, Fibiger HC, Phillips AG. Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system. Psychopharmacology. 1983; 79: 278–283.
- 152 Rocha BA, Fumagalli F, Gainetdinof RR et al. Cocaine self-administration in dopamine transporter knockout mice. Nature Neuroscience. 1998; 1: 132–137.
- 153 Gardner EL. Neurobiology and genetics of addiction: implications of “reward deficiency syndrome” for therapeutic strategies in chemical dependency. In: J Elster, ed. Addiction: Entries and Exits. New York City, NY: Russell Sage;1999: 57–119.
- 154 Routtenberg A. Intracranial chemical injection and behavior: a critical review. Behav Biol. 1972; 7: 601–641.
- 155
Bozarth MA.
Intracranial self-administration procedures for the assessment of drug reinforcement. In: MA Bozarth, ed.
Methods of Assessing the Reinforcing Properties of Abused Drugs. New York City, NY: Springer-Verlag;1987: 173–187.
10.1007/978-1-4612-4812-5_9 Google Scholar
- 156 Bozarth MA. Opiate reward mechanisms mapped by intracranial self-administration. In: JE Smith, JD Lane, eds. Neurobiology of Opiate Reward Processes. Amsterdam, The Netherlands: Elsevier North Holland Biomedical Press;1983: 331–359.
- 157 Myers RD. Methods for chemical stimulation of the brain. In: RD Myers, ed. Methods in Psychobiology. Vol. 1. New York City, NY: Academic Press;1972: 247–280.
- 158 Myers RD. Handbook of Drug and Chemical Stimulation of the Brain. New York City, NY: Van Nostrand Reinhold;1974.
- 159 Bozarth MA, Wise RA. Electrolytic microinfusion transducer system: an alternative method of intracranial drug application. J Neurosci Methods. 1980; 2: 273–275.
- 160 Phillips AG, Mora F, Rolls ET. Intracerebral self-administration of amphetamine by rhesus monkeys. Neurosci Lett. 1981; 24: 81–86.
- 161 Monaco AP, Hernandez L, Hoebel BG. Nucleus accumbens: site of amphetamine self-administration. Comparison with the lateral ventricle. In: RB Chronister, JF DeFrance, eds. Neurobiology of the Nucleus Accumbens. Brunswick, Me.: Haer Institute;1981: 338–343.
- 162 Hoebel BG, Monaco AP, Hernandez L, et al. Self-injection of amphetamine directly into the brain. Psychopharmacology. 1983; 81: 158–163.
- 163 Goeders NE, Smith JE. Cortical dopaminergic involvement in cocaine reinforcement. Science. 1983; 221: 773–775.
- 164 Bozarth MA, Wise RA. Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci. 1981; 28: 551–555.
- 165 Bozarth MA, Wise RA. Localization of reward-relevant opiate receptors. Natl Inst Drug Abuse Res Monogr Ser. 1982; 41: 158–164.
- 166 Stein EA, Olds J. Direct intracerebral self-administration of opiates in the rat. Society for Neuroscience Abstracts. 1977; 3: 302.
- 167 Olds ME. Hypothalamic substrate for the positive reinforcing properties of morphine in the rat. Brain Res. 1979; 168: 351–360.
- 168 Olds ME. Reinforcing effects of morphine in the nucleus accumbens. Brain Res. 1982; 237: 429–440.
- 169 Van Ree JM, De Wied D. Involvement of neurohypophyseal peptides in drug-mediated adaptive responses. Pharmacol Biochem Behav. 1980; 13(suppl 1): 257–263.
- 170 Goeders NE, Lane JD, Smith JE. Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol Biochem Behav. 1984; 20: 451–455.
- 171 Olds ME, Williams KN. Self-administration of D-ala2-met-enkephalinamide at hypothalamic self-stimulation sites. Brain Res. 1980; 194: 155–170.
- 172 McBride WJ, Murphy JM, Gatto GJ, et al. CNS mechanisms of alcohol self-administration. Alcohol Alcohol. 1993; 2(suppl): 463–467.
- 173 Carlezon WA Jr, Wise RA. Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci. 1996; 16: 3112–3122.
- 174 Bozarth MA, Wise RA. Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science. 1984; 244: 516–517.
- 175 Gardner EL, Chen J, Paredes W. Overview of chemical sampling techniques. J Neurosci Methods. 1993; 48: 173–197.
- 176 Hurd YL, Weiss F, Koob G, et al. The influ-ence of cocaine self-administration on in vivo dopamine and acetylcholine neurotransmission in rat caudate-putamen. Neurosci Lett. 1990; 109: 227–233.
- 177 Pettit HO, Pan H-T, Parsons LH, et al. Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. J Neurochem. 1990; 55: 798–804.
- 178 Pettit HO, Justice JB Jr. Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo micro-dialysis. Pharmacol Biochem Behav. 1989; 34: 899–904.
- 179 Wise RA. In vivo estimates of extracellular dopamine and dopamine metabolite levels during intravenous cocaine or heroin self-administration. Seminars in the Neuro-sciences. 1993; 5: 337–342.
- 180 Wise RA, Newton P, Leeb K, et al. Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats. Psychopharmacology. 1995; 120: 10–20.
- 181 Pettit HO, Justice JB Jr. Effect of dose on cocaine self-administration behavior and dopamine levels in the nucleus accumbens. Brain Res. 1991; 539: 94–102.
- 182 Parsons LH, Koob GF, Weiss F. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exp Ther. 1995; 274: 1182–1191.
- 183 Phillips AG, Broekkamp CL, Fibiger HC. Strategies for studying the neurochemical substrates of drug reinforcement in rodents. Prog Neuropsychopharmacol Biol Psychiat. 1983; 7: 585–590.
- 184 Wise RA, Leone P, Rivest R, et al. Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration. Synapse. 1995; 21: 140–148.
- 185 Hemby SE, Martin TJ, Co C, et al. The effects of intravenous heroin administration on extracellular nucleus accumbens dopamine concentrations as determined by in vivo microdialysis. J Pharmacol Exp Ther. 1995; 273: 591–598.
- 186 Weiss F, Lorang MT, Bloom FE, et al. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. J Pharmacol Exp Ther. 1993; 267: 250–258.
- 187 Chang JY, Sawyer SF, Lee RS, et al. Electro-physiological and pharmacological evidence for the role of the nucleus accumbens in cocaine self-administration in freely moving rats. J Neurosci. 1994; 14: 1224–1244.
- 188 Henriksen SJ, Callaway CW, Negus SS, et al. Properties of neurons recorded in the rodent nucleus accumbens, in vivo: relationship to behavioral state and heroin self-administration. Soc Neurosci Abstr. 1992; 18: 373.
- 189 Peoples LL, West MO. Phasic firing of single neurons in the rat nucleus accumbens correlated with the timing of intravenous cocaine self-administration. J Neurosci. 1996; 16: 3459–3473.
- 190 Peoples LL, Uzwiak AJ, Gee F, et al. Operant behavior during sessions of intravenous cocaine infusion is necessary and sufficient for phasic firing of single nucleus accumbens neurons. Brain Res. 1997; 757: 280–284.
- 191 Uzwiak AJ, Guyette FX, West MO, et al. Neurons in accumbens sub-territories of the rat: phasic firing time-locked within seconds of intravenous cocaine self-infusion. Brain Res. 1997; 767: 363–369.
- 192 Peoples LL, Uzwiak AJ, Guyette FX, et al. Tonic inhibition of single nucleus accumbens neurons in the rat: a predominant but not exclusive firing pattern induced by cocaine self-administration sessions. Neuroscience. 1998; 86: 13–22.
- 193 Peoples LL, Gee F, Bibi R, et al. Phasic firing time locked to cocaine self-infusion and locomotion: dissociable firing patterns of single nucleus accumbens neurons in the rat. J Neurosci. 1998; 18: 7588–7598.
- 194 Peoples LL, Uzwiak AJ, Gee F, et al. Phasic accumbal firing may contribute to the regulation of drug taking during intravenous cocaine self-administration sessions. Ann NY Acad Sci. 1999; 877: 781–787.
- 195 Apicella P, Ljungberg T, Scarnati E, et al. Responsesto reward in monkey dorsal and ventral striatum. Exp Brain Res. 1991; 85: 491–500.
- 196 Schultz W, Apicella P, Scarnati E, et al. Neuronal activity in monkey ventral striatum related to the expectation of reward. J Neurosci. 1992; 12: 4595–4610.
- 197 Ljungberg T, Apicella P, Schultz W. Responses of monkey dopamine neurons during learning of behavioral reactions. J Neurophysiol. 1992; 67: 145–163.
- 198 Apicella P, Scarnati E, Ljungberg T, et al. Neuronal activity in monkey striatum related to the expectation of predictable environmental events. J Neurophysiol. 1992; 68: 945–960.
- 199 Schultz W, Apicella P, Ljungberg T. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J Neurosci. 1993; 13: 900–913.
- 200 Mirenowicz J, Schultz W. Importance of unpredictability for reward responses in primate dopamine neurons. J Neurophysiol. 1994; 72: 1024–1027.
- 201 Schultz W. Behavior-related activity of primate dopamine neurons. Rev Neurologique. 1994; 150: 634–639.
- 202 Mirenowicz J, Schultz W. Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature. 1996; 379: 449–451.
- 203 Bowman EM, Aigner TG, Richmond BJ. Neural signals in the monkey ventral striatum related to motivation for juice and cocaine rewards. J Neurophysiol. 1996; 75: 1061–1073.
- 204 Carelli RM, Deadwyler SA. Cellular mechanisms underlying reinforcement-related processing in the nucleus accumbens: electrophysiological studies in behaving animals. Pharmacol Biochem Behav. 1997; 57: 495–504.
- 205 Cannon DS, Carrell LE. Rat strain differences in ethanol self-administration and taste aversion. Pharmacol Biochem Behav. 1987; 28: 57–63.
- 206 George FR. Genetic and environmental factors in ethanol self-administration. Pharmacol Biochem Behav. 1987; 27: 379–384.
- 207 Li TK, Lumeng L. Alcohol preference and voluntary alcohol intakes of inbred rat strains and the National Institutes of Health heterogeneous stock of rats. Alcoholism. 1984; 8: 485–486.
- 208 Ritz MC, George FR, DeFiebre CM, et al. Genetic differences in the establishment of ethanol as a reinforcer. Pharmacol Biochem Behav. 1986; 24: 1089–1094.
- 209 Suzuki T, George FR, Meisch RA. Differential establishment and maintenance of oral ethanol reinforced behavior in Lewis and Fischer 344 inbred rat strains. J Pharmacol Exp Ther. 1988; 245: 164–170.
- 210 George FR, Meisch RA. Oral narcotic intake as a reinforcer: genotype x environment interaction. Behav Genet. 1984; 14: 603.
- 211 Khodzhagel'diev T. Formirovanie vlecheniiak nikotinu u myshei linii C57BL/6 i CBA [Development of nicotine preference in C57BL/6 and CBA mice}. Biul Eksp Biol Med. 1986; 101: 48–50.
- 212 George FR, Goldberg SR. Genetic approaches to the analysis of addiction processes. Trends Pharmacol Sci. 1989; 10: 78–83.
- 213 Kosten TA, Miserendino MJ, Chi S, et al. Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion. J Pharmacol Exp Ther. 1994; 269: 137–144.
- 214 Nestler EJ. Molecular mechanisms of drug addiction in the mesolimbic dopamine pathway. Seminars in the Neurosciences. 1993; 5: 369–376.
- 215 Gardner EL, Lowinson JH. Marijuana's interaction with brain reward systems: update 1991. Pharmacol Biochem Behav. 1991; 40: 571–580.
- 216 Chen J, Paredes W, Lowinson JH, et al. Strain-specific facilitation of dopamine efflux by Δ9-tetrahydrocannabinol in the nucleus accumbens of rat: an in vivo microdialysis study. Neurosci Lett. 1991; 129: 136–140.
- 217 Gardner EL, Paredes W, Smith D, et al. Strain-specific facilitation of brain stimulation reward by Δ9-tetrahydrocannabinol in laboratory rats. Psychopharmacology. 1988; 96(suppl): 365.
- 218 Lepore M, Liu X, Savage V, et al. Genetic differences in Δ9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains. Life Sci [Pharmacol Lett.} 1996; 25: PL365–PL372.
- 219 Lepore M, Vorel R, Gardner EL. Studies on the neurobiological interrelationship between vulnerability to depression and vulnerability to drug abuse in animal models. Behav Pharmacol. 1995; 6(suppl.1): 82–84.
- 220 Lepore M, Gardner EL. Neurobiological relationship between vulnerability to depression and to drug abuse: in vivo microdialysis studies. Soc Neurosci Abstr. 1995; 21: 1955.
- 221
Horan B,
Smith M,
Gardner EL, et al.
(Δ)-Nicotine produces conditioned place preference in Lewis, but not Fischer, 344 rats.
Synapse. 1997; 26: 93–94.
10.1002/(SICI)1098-2396(199705)26:1<93::AID-SYN10>3.0.CO;2-W CAS PubMed Web of Science® Google Scholar
- 222 Guitart X, Beitner-Johnson D, Marby DW, et al. Fischer and Lewis rat strains differ in basal levels of neurofilament proteins and their regulation by chronic morphine in the mesolimbic dopamine system. Synapse. 1992; 12: 242–253.
- 223 Dyr W, McBride WJ, Lumeng TK, et al. Effects of D1 and D2 dopamine receptor agents on ethanol consumption in the high-alcohol-drinking (HAD) line of rats. Alcohol. 1993; 10: 207–212.
- 224 McBride WJ, Chernet JE, Dyr W, et al. Densities of dopamine D2 receptors are reduced in CNS regions of alcohol preferring P rats. Alcohol. 1993; 10: 387–390.
- 225 Zhou FC, Zhang JK, Lumeng L, et al. Mesolimbic dopamine system in alcohol-preferring rats. Alcohol. 1995; 12: 403–412.
- 226 Uhl GR, Elmer GI, Labuda MC, et al. Genetic influencesin drug abuse. In: FE Bloom, DJ Kupfer, eds. Psychopharmacology: The Fourth Generation of Progress. New York City, NY: Raven Press;1995: 1793–1806.
- 227 Blum K, Cull JG, Braverman ER, et al. Reward deficiency syndrome. Am Sci. 1996; 84: 132–145.
- 228 Rouge-Pont R, Piazza PV, Kharouby M, et al. Higher and longer stress-induced increase in dopamine concentrations in the nucleus accumbens of animals predisposed to amphetamine self-administration. A micro-dialysis study. Brain Res. 1993; 602: 169–174.
- 229 Glick SD, Raucci J, Wang S, et al. Neuro-chemical predisposition to self-administer cocaine in rats: individual differences in dopamine and its metabolites. Brain Res. 1994; 653: 148–154.
- 230 Glick SD, Merski C, Steindorf S, et al. Neuro-chemical predisposition to self-administer morphine in rats. Brain Res. 1992; 578: 215–220.
- 231 Piazza PV, Deminiere JM, Le Moal M, et al. Factors that predict individual vulnerability to amphetamine self-administration. Science. 1989; 245: 1511–1513.
- 232 Piazza PV, Rouge-Pont R, Deminiere JM, et al. Individual vulnerability to amphetamine self-administration is correlated with dopaminergic activity in frontal cortex and nucleus accumbens. Soc Neurosci Abstr. 1990; 16: 585.
- 233 Gerber GJ, Stretch R. Drug-induced reinstatement of extinguished self-administration behavior in monkeys. Pharmacol Biochem Behav. 1975; 3: 1055–1061.
- 234 Stewart J. Conditioned and unconditioned drug effects in relapse to opiate and stimulant drug self-administration. Prog Neuro-psychopharmacol Biol Psychiat. 1983; 7: 591–597.
- 235 Stewart J, Wise RA. Reinstatement of heroin self-administration habits: morphine prompts and naltrexone discourages renewed responding after extinction. Psycho-pharmacology. 1992; 108: 79–84.
- 236 Stewart J. Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area. Pharmacol Biochem Behav. 1984; 20: 917–923.
- 237 Stewart J, Vezina P. A comparison of the effects of intra-accumbens injections of amphetamine and morphine on reinstatement of heroin intravenous self-administration behavior. Brain Res. 1988; 457: 287–294.
- 238 Wise RA, Murray A, Bozarth MA. Bromocriptine self-administration and bromo-criptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats. Psychopharmacology. 1990; 100: 355–360.
- 239 De Vries TJ, Schoffelmeer AN, Binnekade R, et al. Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration. Psychopharmacology. 1999; 142: 254–260.
- 240 Shaham Y, Stewart J. Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats. Psychopharmacology. 1996; 125: 385–391.
- 241 Self DW, Barnhart WJ, Lehman DA, et al. Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science. 1996; 271: 1586–1589.
- 242 Self DW. Neural substrates of drug craving and relapse in drug addiction. Ann Med. 1998; 30: 379–389.
- 243 Sutton MA, Karanian DA, Self DW. Factors that determine a propensity for cocaine-seeking behavior during abstinence in rats. Neuropsychopharmacology. 2000; 22: 626–641.
- 244 Self DW, Nestler EJ. Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Depend. 1998; 51: 49–60.
- 245 Shaham Y. Immobilization stress-induced oral opioid self-administration and withdrawal in rats: role of conditioning factors and the effect of stress on “relapse” to opioid drugs. Psychopharmacology. 1993; 111: 477–485.
- 246 Buczek Y, Le AD, Stewart J, et al. Stress reinstates nicotine seeking but not sucrose solution seeking in rats. Psychopharmacology. 1999; 144: 183–188.
- 247 Shaham Y, Funk D, Erb S, et al. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci. 1997; 17: 2605–2614.
- 248 Shaham Y, Erb S, Leung S, et al. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor, attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology. 1998; 137: 184–190.
- 249 Erb S, Shaham Y, Stewart J. The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci. 1998; 18: 5529–5536.
- 250 Shaham Y, Highfield D, Delfs J, et al. Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons. Eur J Neurosci. 2000; 12: 292–302.
- 251 Erb S, Hitchcott PK, Rajabi H, et al. Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology. 2000; 23: 138–150.
- 252 Highfield D, Clements A, Shalev U, et al. Involvement of the medial septum in stress-induced relapse to heroin seeking in rats. Eur J Neurosci. 2000; 12: 1705–1713.
- 253 Gracy KN, Dankiewicz LA, Weiss F, et al. Heroin-specific stimuli reinstate operant heroin-seeking behavior in rats after prolonged extinction. Pharmacol Biochem Behav. 2000; 65: 489–494.
- 254 Katner, SN, Weiss F. Ethanol-associated olfactory stimuli reinstate ethanol-seeking behavior after extinction and modify extracellular dopamine levels in the nucleus accumbens. Alcohol Clin Exp Res. 1999; 23: 1751–1760.
- 255 Weiss F, Maldonado-Vlaar CS, Parsons LH, et al. Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens. Proc Natl Acad Sci USA. 2000; 97: 4321–4326.
- 256 Maldonado-Irizarry CS, Smith D, Koob GF, et al. Blockade of D-1 and D-2 receptors alters “relapse” elicited by cocaine-associated environmental stimuli following prolonged extinction. Soc Neurosci Abstr. 1996; 22: 925.
- 257 LeDoux JE. Emotional memory systems in the brain. Behav Brain Res. 1993; 58: 69–79.
- 258 LeDoux JE. How the brain processes emotional information. Ann NY Acad Sci. 1997; 821: 259–270.
- 259 LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci. 2000; 23: 155–184.
- 260 Muller J, Corodimas KP, Fridel Z, et al. Functional inactivation of the lateral and basal nuclei of the amygdala by muscimol infusion prevents fear conditioning to an explicit conditioned stimulus and to contextual stimuli. Behav Neurosci. 1997; 111: 683–691.
- 261 Hiroi N, White NM. The lateral nucleus of the amygdala mediates expression of the amphetamine-produced conditioned place preference. J Neurosci. 1991; 11: 2107–2116.
- 262 White NM, Hiroi N. Amphetamine conditioned cue preference and the neurobiology of drug-seeking. Seminars in the Neurosciences. 1993; 5: 329–336.
- 263 Hiroi N, White NM. The reserpine-sensitive dopamine pool mediates (+)-amphetamine-conditioned reward in the place preference paradigm. Brain Res. 1990; 510: 33–42.
- 264 Hiroi N, White NM. The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas. Brain Res. 1991; 552: 141–152.
- 265 Nader K, LeDoux JE. Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations. Behav Neurosci. 1999; 113: 891–901.
- 266 Meil WM, See RE. Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine. Behav Brain Res. 1997; 87: 139–148.
- 267 Grimm JW, See RE. Dissociation of primary and secondary reward-relevant limbic nuclei in an animal model of relapse. Neuro-psychopharmacology. 2000; 22: 473–479.
- 268 Kalivas PW, Churchill L, Klitenick MA. GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience. 1993; 57: 1047–1060.
- 269 Sesack SR, Pickel VM. Ultrastructural relationships between terminals immunoreactive for enkephalin, GABA, or both transmitters in the rat ventral tegmental area. Brain Res. 1995; 672: 261–275.
- 270 Kalivas PW, Duffy P, Eberhardt H. Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists. J Pharmacol Exp Ther. 1990; 253: 858–866.
- 271 Klitenick MA, DeWitte P, Kalivas PW. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J Neurosci. 1992; 12: 2623–2632.
- 272 Christie MJ, Summers RJ, Stephenson JA, Cook CJ, Beart PM. Excitatory amino acid projections to the nucleus accumbens septi in the rat: a retrograde transport study utilizing D[3H}aspartate and [3H}GABA. Neuroscience. 1987; 22: 425–439.
- 273 Kiyatkin EA, Rebec GV. Modulation of striatal neuronal activity by glutamate and GABA: iontophoresis in awake, unrestrained rats. Brain Res. 1999; 822: 88–106.
- 274 Meredith GE. The synaptic framework for chemical signalling in nucleus accumbens. Ann NY Acad Sci. 1999; 877: 140–156.
- 275 Yan Q. Focal bicuculline increases extracellular dopamine concentration in the nucleus accumbens of freely moving rats as measured by in vivo microdialysis. Eur J Pharmacol. 1999; 385: 7–13.
- 276 Ward BO, Somerville EM, Clifton PG. Intraaccumbens baclofen selectively enhances feeding behavior in the rat. Physiol Behav. 2000; 68: 463–468.
- 277 Carr DB, Sesack SR. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and meso-cortical neurons. J Neurosci. 2000; 20: 3864–3873.
- 278 Sesack SR, Pickel VM. Prefrontal cortical efferents in the rat synapse on unlabelled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol. 1992; 320: 145–160.
- 279 Self DW, Nestler EJ. Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci. 1995; 18: 463–495.
- 280 Graybiel AM. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 1990; 13: 244–254.
- 281 Gerfen CR. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 1992; 15: 133–139.
- 282 Kawaguchi Y, Wilson CJ, Augood SJ, et al. Striatal interneurones: chemical physiological and morphological characterization. Trends Neurosci. 1995; 18: 527–535.
- 283 Smith AD, Bolam JP. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons. Trends Neurosci. 1990; 13: 259–265.
- 284 Bolam JP, Bennett BD. Microcircuitry of the neostriatum. In: MA Ariano, DJ Surmeier, eds. Molecular and Cellular Mechanisms of Neostriatal Function. New York City, NY: RG Landes;1995: 1–19.
- 285 Maneuf YP, Mitchell IJ, Crossman AR, et al. On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus. Exp Neurol. 1994; 125: 65–71.
- 286 Chrobak JJ, Napier TC. Opioid and GABA modulation of accumbens-evoked ventral pallidal activity. J Neural Transm Gen Sect. 1993; 93: 123–143.
- 287 Nazzaro JM, Gardner EL. GABA antagonism lowers self-stimulation thresholds in the ventral tegmental area. Brain Res. 1980; 189: 279–283.
- 288 Saul'skaya NB, Gorbachevskaya AI. The role of the hippocampal formation in controlling GABA release in the nucleus accumbens during an emotional conditioned response. Neurosci Behav Physiol. 1999; 29: 461–466.
- 289 Richardson NR, Roberts DCS. Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods. 1996; 66: 1–11.
- 290 Roberts DCS, Andrews MM, Vickers GJ. Baclofen attenuates the reinforcing effects of cocaine. Neuropsychopharmacology. 1996; 15: 417–423.
- 291 Brebner K, Phelan R, Roberts DCS. Effects of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules. Psychopharmacology. 2000; 148: 314–321.
- 292 Roberts DCS, Andrews MM. Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure. Psychopharmacology. 1997; 131: 271–277.
- 293 Brebner K, Froestl W, Andrews M, et al. The GABAB agonist CGP 44532 decreases cocaine self-administration in rats: demonstration using a progressive ratio and a discrete trials procedure. Neuropharmacology. 1999; 38: 1797–1804.
- 294 Xi ZX, Stein EA. Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. J Pharmacol Exp Ther. 1999; 290: 1369–1374.
- 295 Jung MJ, Lippert B, Metcalf BW, et al. γ-Vinyl GABA (4–amino-hex-5–enoic acid), a new selective inhibitor of GABA-T: effects on brain GABA metabolism in mice. J Neurochem. 1977; 29: 797–802.
- 296 Mattson RH, Petroff OA, Rothman D, et al. Vigabatrin: effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy. Acta Neurol Scan Suppl. 1995; 162: 27–30.
- 297 Kushner SA, Dewey SL, Kornetsky C. The irreversible γ-aminobutyric acid (GABA) trans-aminase inhibitor γ-vinyl-GABA blocks cocaine self-administration in rats. J Pharmacol Exp Ther. 1999; 290: 797–802.
- 298
Dewey SL,
Chaurasia CS,
Chen C-E, et al.
GABAergic attenuation of cocaine-induced dopamine release and locomotor activity.
Synapse. 1997; 25: 393–398.
10.1002/(SICI)1098-2396(199704)25:4<393::AID-SYN11>3.0.CO;2-W CAS PubMed Web of Science® Google Scholar
- 299
Morgan AE,
Dewey SL.
Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine.
Synapse. 1998; 28: 60–65.
10.1002/(SICI)1098-2396(199801)28:1<60::AID-SYN7>3.0.CO;2-A CAS PubMed Web of Science® Google Scholar
- 300
Dewey SL,
Morgan AE,
Ashby CR Jr, et al.
A novel strategy for the treatment of cocaine addiction.
Synapse. 1998; 30: 119–129.
10.1002/(SICI)1098-2396(199810)30:2<119::AID-SYN1>3.0.CO;2-F CAS PubMed Web of Science® Google Scholar
- 301
Dewey SL,
Brodie JD,
Gerasimov M, et al.
A pharmacologic strategy for the treatment of nicotine addiction.
Synapse. 1999; 31: 76–86.
10.1002/(SICI)1098-2396(199901)31:1<76::AID-SYN10>3.0.CO;2-Y CAS PubMed Web of Science® Google Scholar
- 302 Schiffer WK, Gerasimov MR, Bermel RA, et al. Stereoselective inhibition of dopaminergic activity by gamma vinyl-GABA following a nicotine or cocaine challenge: a PET/microdialysis study. Life Sci [Pharmacol Lett.} 2000; 66: PL169–PL173.
- 303
Gerasimov MR,
Ashby CR Jr,
Gardner EL, et al.
Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine.
Synapse. 1999; 34: 11–19.
10.1002/(SICI)1098-2396(199910)34:1<11::AID-SYN2>3.0.CO;2-5 CAS PubMed Web of Science® Google Scholar
- 304 Gerasimov MR, Dewey SL. Gamma-vinyl γ-aminobutyric acid attenuates the synergistic elevations of nucleus accumbens dopamine produced by a cocaine/heroin (speedball) challenge. Eur J Pharmacol. 1999; 380: 1–4.
- 305
Ashby CR Jr,
Rohatgi R,
Ngosuwan J, et al.
Implication of the GABAB receptor in gamma vinyl-GABA's inhibition of cocaine-induced increases in nucleus accumbens dopamine.
Synapse. 1999; 31: 151–153.
10.1002/(SICI)1098-2396(199902)31:2<151::AID-SYN8>3.0.CO;2-W CAS PubMed Web of Science® Google Scholar
- 306 Gerasimov MR, Schiffer WK, Brodie JD, et al. γ-Aminobutyric acid mimetic drugs differentially inhibit the dopaminergic response to cocaine. Eur J Pharmacol. 2000; 395: 129–135.
- 307 Xi Z-X, Gorsline GJ, Tang J, et al. Effects of GABA-transaminase inhibitors and GABA uptake inhibitors on heroin self-administration behavior. Soc Neurosci Abstr. 1999; 25: 558.
